Prostate cancer prevention by nutritional means to alleviate metabolic syndrome

American Journal of Clinical Nutrition

Volumn 86, Issue 3, 2007, Pages

  Barnard, R James ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Exercise; IGF I; IGFBP 1; Insulin; Insulin like growth factor I; LNCaP; p53

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

BLOOD; CELL CULTURE; DIET THERAPY; EXERCISE; HUMAN; LOW CALORY DIET; LOW FAT DIET; MALE; METABOLIC SYNDROME X; METABOLISM; NUTRITION; PHYSIOLOGY; PROSTATE TUMOR; REVIEW; RISK FACTOR;

DIET, FAT-RESTRICTED; DIET, REDUCING; EXERCISE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; METABOLIC SYNDROME X; NUTRITION PHYSIOLOGY; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR CELLS, CULTURED;

EID: 40349092928     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (62)

1. Cushman SW, Wardzala LJ. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 1980;255:4758-62. (Pubitemid 10060754)
2. Suzuki K, Kono T. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci U S A 1980;77:2542-5. (Pubitemid 10049817)
3. Grimditch GK, Barnard RJ, Kaplan SA, Sternlicht E. Insulin binding and glucose transport in rat skeletal muscle sarcolemmal vesicles. Am J Physiol 1985;249:E398-408. (Pubitemid 16201165)
4. Sternlicht E, Barnard RJ, Grimditch GK. Mechanism of insulin action on glucose transport in rat skeletal muscle. Am J Physiol 1988;254:E633-8.
5. Barnard RJ, Lawani LO, Martin DA, Youngren JF, Singh R, Scheck SH. Effects of maturation and aging on the skeletal muscle glucose transport system. Am J Physiol 1992;262:E619-26.
6. Barnard RJ, Youngren JF, Martin DA. Diet, not aging, causes skeletal muscle insulin resistance. Gerontology 1995;41:205-11.
7. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. (Pubitemid 19004941)
8. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-22.
9. Barnard RJ, Faria DJ, Menges JE, Martin DA. Effects of a high-fat, sucrose diet on serum insulin and related atherosclerotic risk factors in rats. Atherosclerosis 1993;100:229-36. (Pubitemid 23183722)
10. Barnard RJ, Youngren JF, Scheck SH. Reversibility of diet-induced skeletal muscle insulin resistance. Diabetes Res 1997;32:213-21.
11. Roberts CK, Vaziri ND, Liang KH, Barnard RJ. Reversibility of chronic experimental syndrome X by diet modification. Hypertension 2001;37:1323-8. (Pubitemid 34163589)
12. Barnard RJ, Ugianskis EJ, Martin DA, Inkeles SB. Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors. Am J Cardiol 1992;69:440-4.
13. Barnard RJ, Aronson WJ, Tymchuk CN, Ngo TH. Prostate cancer: another aspect of the insulin-resistance syndrome? Obes Rev 2002;3:303-8. (Pubitemid 35364690)
14. Katsuki A, Sumida Y, Murashima S, et al. Acute and chronic regulation of serum sex hormone-binding globulin levels by plasma insulin concentrations in male noninsulin-dependent diabetes mellitus patients. J Clin Endocrinol Metab 1996;81:2515-9. (Pubitemid 26240270)
15. Pasquali R, Casimirri F, De Iasio R, et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab 1995;80:654-8.
16. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988;67:460-4.
17. Strain G, Zumoff B, Rosner W, Pi-Sunyer X. The relationship between serum levels of insulin and sex hormone-binding globulin in men: the effect of weight loss. J Clin Endocrinol Metab 1994;79:1173-6. (Pubitemid 24342268)
18. Tymchuk CN, Tessler SB, Aronson WJ, Barnard RJ. Effects of diet and exercise on insulin, sex hormone-binding globulin, and prostate-specific antigen. Nutr Cancer 1998;31:127-31. (Pubitemid 28428073)
19. Tymchuk CN, Barnard RJ, Heber D, Aronson WJ. Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol 2001;166:1185-9. (Pubitemid 32751066)
20. Tymchuk CN, Barnard RJ, Ngo TH, Aronson WJ. Role of testosterone, estradiol, and insulin in diet-and exercise-induced reductions in serum-stimulated prostate cancer cell growth in vitro. Nutr Cancer 2002;42:112-6. (Pubitemid 35007014)
21. Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control 2002;13:929-35. (Pubitemid 36169476)
22. Ngo TH, Barnard RJ, Leung PS, Cohen P, Aronson WJ. Insulin-like growth factor I (IGF-I) and IGF binding protein-1 (IGFBP-1) modulates prostate cancer cell growth and apoptosis: a possible mediators for the effects of diet and exercise on cancer cell survival. Endocrinology 2003;144:2319-24. (Pubitemid 36629883)
23. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000;92:1472-89.
24. Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev 2001;20:225-43. (Pubitemid 34600970)
25. Barnard RJ, Ngo TH, Leung PS, Aronson WJ, Golding LA. A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate 2003;56:201-6. (Pubitemid 36918170)
26. Ngo TH, Barnard RJ, Cohen P, et al. Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficiency mice and the insulin-like growth factor axis. Clin Cancer Res 2003;9:2734-43. (Pubitemid 36842120)
27. Kondo Y, Homma Y, Aso Y, Kakizoe T. Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats. Cancer Res 1994;54:6129-32. (Pubitemid 24378643)
28. Pollard M, Luckert PH. Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett 1986;32:223-7. (Pubitemid 16017134)
29. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 1995;87:1456-62.
30. Kobayashi N, Barnard RJ, Henning SM, et al. Effect of altering dietary omega-6:omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxzygenase-2 and prostaglandin E-2. Clin Cancer Res 2006;12:4462-70.
31. Augustsson K, Michaud DS, Rimm EB, et al. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev 2003;12:64-7. (Pubitemid 36110160)
32. Leitzmann MF, Stampfer MJ, Michaud DS, et al. Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 2004;80:204-16.
33. Norrish AE, Skeaff CM, Arribas GL, Sharpe SJ, Jackson RT. Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study. Br J Cancer 1999;81:1238-42.
34. Terry P, Lichtenstein P, Feychting M, Ahlbom A, Wolk A. Fatty fish consumption and risk of prostate cancer. Lancet 2001;357:1764-6. (Pubitemid 32524210)
35. MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 2006;295:403-15. (Pubitemid 43144977)
36. Ablin RJ, Shaw MW. Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res 1986;6:327-8. (Pubitemid 16115120)
37. Bartsch H, Nair J, Owen RW. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis 1999;20:2209-18. (Pubitemid 30015890)
38. Hansen HS. Dietary essential fatty acids and in vivo prostaglandin production in mammals. World Rev Nutr Diet 1983;42:102-34.
39. Levy GN. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J 1997;11:234-47. (Pubitemid 27118324)
40. Wang D, Dubois RN. Prostaglandins and cancer. Gut 2006;55:115-22. (Pubitemid 41820645)
41. Youngren JF, Paik J, Barnard RJ. Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulin-resistant rats. J Appl Physiol 2001;91:2240-7. (Pubitemid 33015079)
42. Roberts CK, Vaziri ND, Wang XQ, Barnard RJ. Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet. Hypertension 2000;36:423-9.
43. McTernan PG, Anwar A, Eggo MC, Barnett AH, Stewart PM, Kumar S. Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue. Int J Obes Relat Metab Disord 2000;24:875-81. (Pubitemid 30449923)
44. Subbaramaiah K, Howe LR, Port ER, et al. HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism. Cancer Res 2006;66:5504-11. (Pubitemid 43844979)
45. Westley BR, May FE. Role of insulin-like growth factors in steroid modulated proliferation. J Steroid Biochem Mol Biol 1994;51:1-9. (Pubitemid 24340040)
46. Heron-Milhavet L, Karas M, Goldsmith CM, Baum BJ, LeRoith D. Insulin-like growth factor-I (IGF-I) receptor activation rescues UV-damaged cells through a p38 signaling pathway. Potential role of the IGF-I receptor in DNA repair. J Biol Chem 2001;276:18185-92.
47. Heron-Milhavet L, LeRoith D. Insulin-like growth factor I induces MDM2-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage. J Biol Chem 2002;277:15600-6. (Pubitemid 34967830)
48. Parrizas M, LeRoith D. Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology 1997;138:1355-8. (Pubitemid 27089798)
49. Barnard RJ, Leung PS, Aronson WJ, Cohen P, Golding LA. A mechanism to explain how regular exercise reduces the risk for clinical prostate cancer. Eur J Cancer Prev (in press).
50. Leung PS, Aronson WJ, Ngo TH, Golding LA, Barnard RJ. Exercise enhancement of the p53 protein product in LNCaP prostate cancer cells. J Appl Physiol 2004;96:450-4. (Pubitemid 38140142)
51. Hammarsten J, Hogstedt B. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 2005;41:2887-95. (Pubitemid 41713128)
52. Laukkanen JA, Laaksonen DE, Niskanen L, Pukkala E, Hakkarainen A, Salonen JT. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev 2004;13:1646-50. (Pubitemid 39331887)
53. Ornish DM, Lee KL, Fair WR, Pettengill EB, Carroll PR. Dietary trial in prostate cancer: early experience and implications for clinical trial design. Urology 2001;57:200-1. (Pubitemid 33733948)
54. Ornish D, Weidner G, Fait WR, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 2005;174:1065-70.
55. Jarred RA, Keikha M, Dowling C, et al. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol Biomarkers Prev 2002;11:1689-96. (Pubitemid 36020026)
56. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 2002;132:552S-8S. (Pubitemid 34208769)
57. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 1999;129:1628-35. (Pubitemid 29406613)
58. Adams KF, Newton KM, Chen C, et al. Soy isoflavones do not modulate circulating insulin-like growth factor concentrations in an older population in an intervention trial. J Nutr 2003;133:1316-9. (Pubitemid 36548700)
59. Gann PH, Kazer R, Chatterton R, et al. Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: effects on circulating IGF-I and its binding proteins in premenopausal women. Int J Cancer 2005;116:297-303. (Pubitemid 40967269)
60. Khalil DA, Lucas EA, Juma S, Smith BJ, Payton ME, Arjmandi BH. Soy protein supplementation increases serum insulin-like growth factor-I in young and old men but does not affect markers of bone metabolism. J Nutr 2002;132:2605-8. (Pubitemid 35013242)
61. Probst-Hensch NM, Wang H, Goh VH, Seow A, Lee HP, Yu MC. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Prev 2003;12:739-46. (Pubitemid 36993164)
62. Spentzos D, Mantzoros C, Regan MM, et al. Minimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patients. Clin Cancer Res 2003;9:3282-7. (Pubitemid 37082721)